Dr. Michael Schweizer
Claim this profileFred Hutch/University of Washington Cancer Consortium
Expert in Prostate Cancer
Studies Skin Cancer
13 reported clinical trials
26 drugs studied
Area of expertise
1Prostate Cancer
Global LeaderStage IV
L1CAM positive
Stage III
2Skin Cancer
L1CAM positive
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Michael Schweizer is currently running
High-Dose Testosterone + Chemotherapy
for Prostate Cancer
This trial tests if high levels of a hormone combined with cancer treatment can help treat prostate cancer that has spread and is not responding to usual treatments. The hormone may damage cancer cell DNA, and the treatment helps kill or slow the cancer cells.
Recruiting1 award Phase 220 criteria
EP31670
for Advanced Cancer
A Phase 1, first-in-human study of EP31670, a dual BET and CBP/p300 inhibitor in patients with targeted advanced solid tumors and Hematological Malignancies
Recruiting1 award Phase 1
More about Michael Schweizer
Clinical Trial Related4 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Michael Schweizer has experience with
- Olaparib
- Docetaxel
- Enzalutamide
- Carboplatin
- Etoposide
- Testosterone Cypionate
Breakdown of trials Michael Schweizer has run
Prostate Cancer
Skin Cancer
- Erdafitinib and Abiraterone Acetate or Enzalutamide in Treating Patients With Double Negative Prostate Cancer
- Genetically Engineered Cells (MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells) and Atezolizumab for the Treatment of Metastatic Triple Negative Breast Cancer, Urothelial Cancer, or Non-small Cell Lung Cancer
- CAR T-cell Therapy for Prostate Cancer
Prostate Adenocarcinoma
Prostate Carcinoma
Gastroesophageal Junction Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael Schweizer specialize in?
Michael Schweizer focuses on Prostate Cancer and Skin Cancer. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are L1CAM positive.
Is Michael Schweizer currently recruiting for clinical trials?
Yes, Michael Schweizer is currently recruiting for 5 clinical trials in Seattle Washington. If you're interested in participating, you should apply.
Are there any treatments that Michael Schweizer has studied deeply?
Yes, Michael Schweizer has studied treatments such as Olaparib, Docetaxel, Enzalutamide.
What is the best way to schedule an appointment with Michael Schweizer?
Apply for one of the trials that Michael Schweizer is conducting.
What is the office address of Michael Schweizer?
The office of Michael Schweizer is located at: Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington 98109 United States. This is the address for their practice at the Fred Hutch/University of Washington Cancer Consortium.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.